GLP-1 medications may be considered for individuals with obesity or excess weight who have not achieved sufficient results with diet and exercise alone. A licensed healthcare provider will review your medical history to determine whether this option is appropriate for you.

GLP-1 receptor agonists are medications originally developed to manage diabetes that have also been shown to support weight loss. They work by reducing appetite, slowing gastric emptying, and increasing feelings of fullness, which can help decrease overall calorie intake and promote sustained weight reduction.

GLP-1 receptor agonists have demonstrated significant effectiveness in promoting weight loss, often leading to meaningful reductions in body weight, while also improving metabolic markers and supporting better blood sugar control.

GLP-1s are typically administered as a subcutaneous injection, similar to insulin. Depending on the specific medication, injections can be daily, weekly, or even monthly. Your healthcare provider will guide you on the appropriate dosing schedule.

As with any medication, GLP-1 receptor agonists may cause side effects. Commonly reported effects include nausea, vomiting, diarrhea, and constipation, which are typically temporary and improve over time. Your healthcare provider will review potential side effects with you and provide guidance on how to manage them effectively.

Individual results may vary; however, many patients begin to experience noticeable weight loss within several weeks to a few months of initiating GLP-1 therapy. Adherence to treatment, healthy lifestyle habits, and regular follow-up with a healthcare provider are key factors in achieving optimal outcomes.

Yes. GLP-1 therapy can effectively complement other weight management strategies, including dietary modifications and physical activity. When combined with a comprehensive lifestyle approach, GLP-1 medications often produce the most favorable outcomes.

Yes. Several GLP-1 receptor agonists are FDA-approved for the treatment of type 2 diabetes and, in certain formulations, for chronic weight management. Dual GLP-1/GIP agonists are also FDA-approved for type 2 diabetes and chronic weight management, with select agents additionally approved for obesity-related conditions such as obstructive sleep apnea.

Compounded medications are not FDA-approved. They are custom-prepared by specialized pharmacies to meet individual patient needs when commercial products are unavailable or unsuitable.

We work with a 503B FDA-registered outsourcing facility that produces medications under strict quality and sterility standards. These medications are dispensed through 503B pharmacies in compliance with federal and state regulations, while still being customized to meet individual patient needs.

Each compounded prescription is carefully packaged for safe and convenient home use and includes:

• Pre-sterilized syringes in the correct size for your dose.

• Alcohol swabs to clean the injection site and reduce infection risk.

• Medication vial(s) labeled with dosing instructions, lot numbers, and expiration dates.

• Instructional inserts with storage, handling, and safety tips.

Peptides are short chains of amino acids that act as signaling molecules in the body, helping regulate processes such as metabolism, hormone activity, tissue repair, and immune function.

Peptides may be used by adults under the guidance of a licensed healthcare provider when clinically appropriate, based on individual health needs, goals, and medical history.

Peptides may support the body by helping regulate metabolism, improve energy utilization, support tissue repair and recovery, enhance muscle function, promote fat loss, and optimize hormone signaling—depending on the specific peptide and individual clinical needs.